Bought
Maintained
Sold
Other funds holding CME
Nuveen's CME Position: Q2 2026 in Review
Nuveen reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $37.5M and leaving 925,982 shares worth $204M. The position accounts for 0.05% of the portfolio, ranked #273.
Nuveen first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $663M in Q3 2019. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Nuveen held 925,982 shares of CME Group worth $204M as of Q2 2026.
- Nuveen sold 135,575 CME Group shares in Q2 2026, an estimated $37.5M.
- CME Group made up 0.05% of Nuveen's portfolio in Q2 2026, its #273 holding.
- Nuveen first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
- Nuveen's CME Group position peaked at $663M in Q3 2019.
- 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.